Cargando…

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer

Detalles Bibliográficos
Autor principal:	Dowsett, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233501/ http://dx.doi.org/10.1186/bcr1080

Ejemplares similares

Preoperative hormonal therapy: results and implications
por: Dowsett, M
Publicado: (2005)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
por: Coombes, RC, et al.
Publicado: (2005)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

ERβ in normal and malignant breast
por: Gustafsson, J-Å, et al.
Publicado: (2005)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Hormones and radiation as risk factors for breast cancer
por: Beral, V
Publicado: (2006)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

O028 Combination Pharmacological Therapy Targeting Multiple Mechanisms of Sleep Apnea
por: Sands, S, et al.
Publicado: (2022)

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone
por: Carlsten, H, et al.
Publicado: (2004)

Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™
por: Skippage, PL, et al.
Publicado: (2009)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Growth regulation and steroid hormone resistance in breast cancer
por: Horwitz, KB
Publicado: (2000)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer
por: Nowicki, PW, et al.
Publicado: (2009)

Response to growth hormone therapy and gonadal pathology in 45,X/46,XY females
por: Titmuss, Angela, et al.
Publicado: (2015)

Abdominal and pelvic complications of molecular targeted therapy
por: Gore, Richard M, et al.
Publicado: (2014)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Clinical translation of progress in molecular endocrinology
por: Dowsett, M
Publicado: (2000)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Developing new treatments for breast cancer
por: Lane, D
Publicado: (2004)

No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis – a matched pair analysis
por: Schmeling, Heinrike, et al.
Publicado: (2012)

Photodynamic therapy of laryngeal cancers
por: Biel, Merrill
Publicado: (2010)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Locoregional therapy of renal cancer
por: Wah, Tze Min
Publicado: (2014)

Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
por: Gatignol, A, et al.
Publicado: (2014)

Combination therapy with ipilimumab and electrochemotherapy: preliminary efficacy results and correlation with immunological parameters
por: Simeone, Ester, et al.
Publicado: (2014)

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma
por: Nemunaitis, John J, et al.
Publicado: (2014)

S4.1a Fusariosis: MICs, mono versus combination therapy and fosmanogepix
por: Hoenigl, Martin
Publicado: (2022)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_v7vu4eh88ird8635m611fl9sq0